InhaLac® 230
Premium sieved DPI alpha-lactose monohydrate – Ph. Eur., USP-NF, JP, ChP
MEGGLE’s InhaLac® product line is designed to meet the stringent requirements of DPI applications through controlled crystallization and precise milling or sieving. By improving flowability, handling, and dosing accuracy, lactose significantly enhances the performance and therapeutic effectiveness of pulmonary drug delivery systems.
InhaLac® 230 is a sieved lactose monohydrate with a median particle size (x50) of ~97 µm, ideal for capsule or blister-based DPI formulations. It provides excellent flow and blending properties for uniform dosing.
Sieved DPI lactose provides a narrow particle size distribution and enhanced flowability, ensuring consistent dose metering and reliable API release.
Benefits
- Dedicated production process
- Tailor-made products with specific powder characteristics
- Highest microbial quality including low endotoxins
- Available in a broad spectrum of sieve cuts to meet your criteria
Areas of Application
- InhaLac® 230 is a sieved carrier lactose is suitable for use in pulmonary and nasal drug delivery.
Order your free sample!
- Dry Powder Inhalation
- Sieved Lactose DPI
- Inhalation Lactose
- Inhalation
- Nasal
- Dry Powder Inhaler (DPI)
- Reservoir Devices (DPI)
25kg – Carton box with aluminium laminated and PE-EVOH-PE inliner
24 months
Wasserburg am Inn, Germany
Downloads
Typical particle size distribution
Typical Product Data
- x10: 49 µm, x50: 96 µm, x90: 144 µm
- Span [(x90-x10)/x50]: 1
- % fines <5 µm: 2
- Density bulk: 0.73 g/ml
- Density tapped: 0.87 g/ml
- Hausner Ratio: 1.19
- Carr’s Index: 16 %
Specified Product Data
Particle size distribution
Sieve Method: Laser diffraction
- x10: 30-60
- x50: 70-110
- x90: 110-150
Do you have any questions or need a customised solution?